Zomedica Corp. (NYSE: ZOM) reported Q1 EPS of ($0.01), $0.01 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $5.5 million versus the consensus estimate of $6.63 million.

For earnings history and earnings-related data on Zomedica Corp. (ZOM) click here.